机译:非肌肉浸润性膀胱癌最初的细菌卡介苗失败后吉西他滨与卡介苗合并† sup> ‡ sup>
Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy;
|Urology Unit, National Tumor Institute, Pascale Foundation, Naples, Italy;
|Urology Unit, Magna Graecia University, Catanzaro, Italy;
Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy;
Urology Unit, Magna Graecia University, Catanzaro, Italy;
Medical Oncology Unit, National Tumor Institute, Pascale Foundation, Naples, Italy;
Medical Oncology and Innovative Therapy Unit, National Tumor Institute, Pascale Foundation, Naples, Italy;
Medical Oncology and Innovative Therapy Unit, National Tumor Institute, Pascale Foundation, Naples, Italy;
Urology Clinic, Second University of Naples, Naples, Italy;
Urology Clinic, Second University of Naples, Naples, Italy|;
bacille Calmette-Gueacute; rin; failure; gemcitabine; superficial bladder cancer;
机译:非肌肉浸润性膀胱癌中最初的卡介苗-卡格林失败后,吉西他滨与卡介苗合并:一项多中心前瞻性随机试验。
机译:不适合进行根治性膀胱切除术的高危非肌肉浸润性膀胱癌患者中卡介苗的失败率:可用治疗方法的更新
机译:用Bacille Calmette-guérin免疫疗法治疗非肌肉浸润性膀胱癌患者编程细胞死亡蛋白配体1的预后价值:当前状态
机译:非肌肉浸润性膀胱癌中膀胱内BacilleCalmette-Guérin和化学疗法与单独BacilleCalmette-Guérin的组合:荟萃分析
机译:预定介绍粒状吉西他滨的疗效和毒性对TA和T1膀胱癌的Bacille Calmette-Guérin:系统审查和荟萃分析